CCNB1 and familial pancreatic carcinoma: Recently, increasing evidence demonstrated that CCNB1 was over-expressed in considerable cancers with poor prognosis, including hepatocellular carcinoma [29, 30], breast cancer [31, 32], and pancreatic cancer [33, 34].